Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction.

Source:http://linkedlifedata.com/resource/pubmed/id/10841521

Download in:

View as

General Info

PMID
10841521